News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Find A Specialist
Resource Finder at Kennedy Krieger Institute
Submitted by admin on June 23, 2011 - 3:08pm
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Biblio
Found 14 results
2010
Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman MW, Ramaswamy K, Siegmund KD, Lee RD, Ely JJ et al..
2010. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions.. BMC physiology. 10:19. Abstract
2009
Hubbard WC, Moser AB, Liu AC, Jones RO, Steinberg SJ, Lorey F, Panny SR, Vogt RF, Macaya D, Turgeon CT et al..
2009. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.. Molecular genetics and metabolism. 97(3):212-20. Abstract
2008
Savransky V, Jun J, Li J, Nanayakkara A, Fonti S, Moser AB, Steele KE, Schweitzer MA, Patil SP, Bhanot S et al..
2008. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase.. Circulation research. 103(10):1173-80. Abstract
2007
Moser HW, Moser AB, Hollandsworth K, Brereton HN, Raymond GV.
2007. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.. Journal of molecular neuroscience : MN. 33(1):105-13. Abstract
Lu J-F, Barron-Casella E, Deering R, Heinzer AK, Moser AB, deMesy Bentley KL, Wand GS, C McGuinness M, Pei Z, Watkins PA et al..
2007. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage.. Laboratory investigation; a journal of technical methods and pathology. 87(3):261-72. Abstract
Raymond GV, Jones RO, Moser AB.
2007. Newborn screening for adrenoleukodystrophy: implications for therapy.. Molecular diagnosis & therapy. 11(6):381-4. Abstract
2006
Hubbard WC, Moser AB, Tortorelli S, Liu A, Jones D, Moser H.
2006. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.. Molecular genetics and metabolism. 89(1-2):185-7. Abstract
Cox CS, Dubey P, Raymond GV, Mahmood A, Moser AB, Moser HW.
2006. Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.. Archives of neurology. 63(1):69-73. Abstract
Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW.
2006. Peroxisome biogenesis disorders.. Biochimica et biophysica acta. 1763(12):1733-48. Abstract
2005
Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW.
2005. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.. The Journal of pediatrics. 146(4):528-32. Abstract
2003
Heinzer AK, Watkins PA, Lu J-F, Kemp S, Moser AB, Li Y, Mihalik S, Powers JM, Smith KD.
2003. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.. Human molecular genetics. 12(10):1145-54. Abstract
Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song X-yu, Diehl AM.
2003. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.. Hepatology (Baltimore, Md.). 37(2):343-50. Abstract
2002
Tagawa Y, Laroy W, Nimrichter L, Fromholt SE, Moser AB, Moser HW, Schnaar RL.
2002. Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.. Neurochemical research. 27(7-8):847-55. Abstract

